In India, the fast-growing and evolving pharmaceutical sector is undergoing a shift and looking at various avenues such as automation, pre-sales reporting, chronic disease management, compliance and the latest cutting-edge technologies to bring themselves a step ahead of the rest industry players within the region. In a recent study stated that the Indian pharmaceutical market will grow more than four times to reach USD 55 billion by 2020, with the potential to reach USD 70 billion in an aggressive growth scenario. This scenario will be characterized by strong growth in GDP and incomes, insurance coverage, and government and private sector spending on healthcare

Fleming Gulf's inaugural “The Pharma and Drug Manufacturing Summit” will take place on the 8th and 9th of October, 2015 in Mumbai, India to discuss the current challenges and trends, cost-effective methodologies, sharing of best practices and showcasing of emerging technologies that can expedite the pharmaceutical manufacturing process in the region. The summit will host delegations from Cadila Halthcare Limited, Wockhardt, Abbott Nutrition International, TEVA Pharma, Pfizer, PlasmaGen Biosciences, Wanbury Limited, Biocon and many others.

Topics such as 'Big Data Usage, Data Management & Integrity', 'Innovative Technology Transfer, Technology For Vaccine & Clinical Trials', 'Condition Monitoring', 'Quality by Design (QbD) & Process Analytical Technology (PAT)', 'Pharmacovigilance & Traceability' and many more will be imparted to the participants by leading industry specialists. The summit will offer participants and exhibitors with even more opportunities to interact and engage with industry thought leaders and experts, that will help pharmaceutical companies to become more advanced and grow further in the region.